Cazzolla Angela Pia, Testa Nunzio Francesco, Favia Gianfranco, Lacaita Maria Grazia, Ciavarella Domenico, Zhurakivska Khrystyna, Troiano Giuseppe, Lo Muzio Lorenzo
Clinic of Dentistry, University of Bari, Bari, Italy.
Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Spec Care Dentist. 2018 Mar;38(2):107-111. doi: 10.1111/scd.12273. Epub 2018 Feb 8.
Langerhans cell histiocytosis (LCH) is a childhood pathology with a peak of incidence ranging from 1 to 4 years of age, though diagnosis is often made in adult age. LCH is clinically classified into three types: eosinophilic granuloma, Hand-Schuller-Christian disease and Abt-Letterer-Siwe disease. We report a case of Hand-Schüller-Christian disease with diabetes insipidus, skull and maxillary involvement in a 16-year-old boy referred to our observation for gradual increase in mobility of the teeth and subsequent gradual loss of the second premolars and the first molars of the upper jaw. Due to the extension of the lesion and the age of the patient, surgery, and chemotherapy was chosen as the more fit treatment according to the current protocol. The clinical and radiological evaluation at the end of the therapy and after 5 years showed complete remission. The absence of relapse has allowed to initiate a fixed orthodontic dental alignment treatment with a good response to orthodontic treatment despite the underlying disease. The present case exemplifies the importance of close multidisciplinary dental and medical collaboration including general dentistry, periodontology, oral medicine, oral and maxillofacial pathology, oral radiology, orthodontics and hematology-oncology for diagnosis, management, treatment monitoring, and decision-making.
朗格汉斯细胞组织细胞增多症(LCH)是一种儿童期疾病,发病高峰在1至4岁,不过常在成年期才得以诊断。LCH临床上分为三种类型:嗜酸性肉芽肿、汉-许-克病和勒-雪病。我们报告一例16岁男孩患汉-许-克病伴尿崩症、颅骨和上颌受累,该男孩因牙齿松动逐渐加重,随后上颌第二前磨牙和第一磨牙逐渐缺失前来我院就诊。鉴于病变范围及患者年龄,根据现行方案,选择手术及化疗作为更合适的治疗方法。治疗结束时及5年后的临床和影像学评估显示完全缓解。尽管存在基础疾病,但未复发使得可以开始进行固定正畸牙齿排齐治疗,且正畸治疗反应良好。本病例体现了多学科紧密协作的重要性,包括普通牙科、牙周病学、口腔医学、口腔颌面病理学、口腔放射学、正畸学和血液肿瘤学,以进行诊断、管理、治疗监测和决策。